Pharmaco - Press Releases

Date	Title	Company
24-Mar-2022	Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply	B3C newswire
24-Mar-2022	EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial Officer to Support Future Growth	B3C newswire
24-Mar-2022	Epigenomics AG Reports Financial Results for Fiscal Year 2021	Epigenomics AG
24-Mar-2022	RHÖN-KLINIKUM AG looks back on successful financial year 2021	RHÖN-KLINIKUM Aktiengesellschaft
24-Mar-2022	Spexis provides business update and announces financial results for the full-year 2021	Spexis AG
24-Mar-2022	Heidelberg Pharma announces financial figures for fiscal year 2021 and provides business update	Heidelberg Pharma AG
24-Mar-2022	Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued	Zur Rose Group AG
24-Mar-2022	Relief Receives Trademark Registration for RLF-100(R) From the U.S. Patent and Trademark Office	Relief Therapeutics Holding SA
23-Mar-2022	LifeMine Therapeutics and GSK Enter Drug Discovery and Development Alliance	LifeMine Therapeutics
23-Mar-2022	AccuStem Sciences, Inc. Announces DTC Eligibility	AccuStem Sciences, Inc.
23-Mar-2022	atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update	atai Life Sciences
23-Mar-2022	ONK Therapeutics Brings in US Financial Experience with the Appointment of Dr. Allan Reine as Independent Non-Executive Director	ONK Therapeutics
23-Mar-2022	Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials	Eckert & Ziegler Strahlen- und Medizintechnik AG
23-Mar-2022	Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent	Vifor Pharma
23-Mar-2022	Sanofi moves forward with EUROAPI listing on Euronext Paris	Sanofi
23-Mar-2022	Takeda’s EXKIVITY▼(mobocertinib) granted Conditional Marketing Authorisation in Great Britain	Takeda
23-Mar-2022	COSMO ANNOUNCES FULL-YEAR RESULTS 2021; CONFIRMS BEATING GUIDANCE	Cosmo Pharmaceuticals N.V.
22-Mar-2022	MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL	MorphoSys AG
22-Mar-2022	Innovative collaboration to offer heart rhythm checks throughout the North West to detect Atrial Fibrillation via Community Pharmacies	Daiichi Sankyo and O’Brien’s Pharmacies Group
22-Mar-2022	Torsten Buergermeister Joins VERAXA Biotech GmbH as Chief Financial Officer	B3C newswire